MedTrace Logo

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease

NCT00548145 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2012-06-14

Study results available
· View outcomes & findings →

Summary

Some studies suggest that statin medications may be effective against Alzheimer's disease. However, this has not been proven. The purpose of this study is to evaluate the efficacy of pitavastatin in patients with mild to moderate Alzheimer's disease and hypercholesterolemia.

Conditions

Interventions

DRUG

Pitavastatin

2 mg by orally/day Duration: 12 months

DRUG

cholesterol-lowering medicine other than statin(e.g.,Ezetimibe,Colestimide)

duration: 12 months

Sponsors & Collaborators

  • Kowa Company, Ltd.

    collaborator INDUSTRY

  • Osaka University

    lead OTHER

Principal Investigators

  • Hiroaki Kazui, Ph.D. · Osaka University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-10-31
Completion
2012-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548145 on ClinicalTrials.gov